Martin Capital Partners’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$10.6M Buy
40,624
+503
+1% +$133K 3.81% 4
2026
Q2
$8.86M Buy
40,121
+8,549
+27% +$2.36M 3.26% 7
2026
Q1
$9.32M Buy
31,572
+208
+0.7% +$61.8K 3.47% 5
2025
Q4
$8.56M Buy
31,364
+227
+0.7% +$61.7K 3.22% 8
2025
Q3
$8.41M Sell
31,137
-440
-1% -$120K 3.26% 2
2025
Q2
$8.7M Buy
31,577
+22,267
+239% +$6.06M 3.41% 2
2025
Q1
$2.47M Sell
9,310
-429
-4% -$106K 2.95% 9
2024
Q4
$2.26M Sell
9,739
-8,387
-46% -$1.93M 2.68% 10
2024
Q3
$4M Buy
+18,126
New +$3.75M 1.98% 26

Other funds holding CME

Martin Capital Partners's CME Position: Q3 2026 in Review

Martin Capital Partners increased its CME Group (CME) stake by 1.3% in Q3 2026, buying an estimated $133K and bringing the position to 40,624 shares worth $10.6M. The position accounts for 3.81% of the portfolio, ranked #4.

Martin Capital Partners first reported a position in CME in Q3 2024 and has held it in 9 quarters since. 59 funds tracked by Wall St. Rank hold CME as of Q3 2026.

  • Martin Capital Partners held 40,624 shares of CME Group worth $10.6M as of Q3 2026.
  • Martin Capital Partners bought 503 CME Group shares in Q3 2026, an estimated $133K.
  • CME Group made up 3.81% of Martin Capital Partners's portfolio in Q3 2026, its #4 holding.
  • Martin Capital Partners first reported a position in CME Group in Q3 2024 and has held it in 9 quarters since.
  • 59 funds tracked by Wall St. Rank held CME Group as of Q3 2026.

Based on Martin Capital Partners's 13F filing for Q3 2026, filed 7 Oct 2026.